Can you give us a roadmap and detailed rationale for how and when to deploy NGS in the setting of prostate cancer? How do improve the content yields of prostate biopsies? How do we ferret out tumor heterogeneity issues?

Can you give us a roadmap and detailed rationale for how and when to deploy NGS in the setting of prostate cancer? How do improve the content yields of prostate biopsies? How do we ferret out tumor heterogeneity issues?

Can you give us a roadmap and detailed rationale for how and when to deploy NGS in the setting of prostate cancer? How do improve the content yields of prostate biopsies? How do we ferret out tumor heterogeneity issues?